TREA

76272025 - JERINI

Follow

Information

  • Trademark
  • 76272025
  • Serial Number
    76272025
  • Registration Number
    2894095
  • Filing Date
    June 15, 2001
    24 years ago
  • Registration Date
    October 19, 2004
    21 years ago
  • Transaction Date
    July 22, 2011
    14 years ago
  • Status Date
    May 20, 2011
    14 years ago
  • Published for Opposition Date
    July 27, 2004
    21 years ago
  • Location Date
    October 24, 2007
    18 years ago
Information
Mark Drawing Code
1000
Mark Identification
JERINI
Case File Statements
  • GS0011: Chemicals used in industry and science, agriculture, horticulture and forestry, namely, proteins, peptides, peptidomimetics, small molecules, nucleic acids and polynucleotides; proteins and recombinant proteins for scientific research use; peptides for scientific research use; antibodies for scientific research use; DNA probes for scientific research use; oligonucleotides for scientific research use; antisense constructs for scientific research use; arrays of nucleic acids on a carrier material for scientific research use; arrays of proteins on a carrier material for scientific research use; arrays of peptides on a carrier material for scientific research use
  • GS0051: Pharmaceutical and veterinary products, namely, preparations for sanitation, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgesics and antirheumatic drugs, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antiinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolytics, hemostatics, antihypertonics, antihypoglycemics, antihypotonics, anticoagulants, antimycotics, pharmaceuticals functioning as antiparasitics, antiphlogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensin-system, pharmaceuticals functioning as broncholytics, antiasthmetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disinfectants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastrointestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, dacryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologics and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies, and medical plastics, namely sanitary preparations, veterinary preparations for use in the treatment of diseases of pets, livestock, wild animals, breeding animals and zoo animals; dietic supplements adapted for medical use, namely food for elderly people and for medically restricted diets; all-purpose disinfectants; preparations for destroying vermin; fungicides for domestic use; fungicides for agricultural use; herbicides for domestic use; herbicides for agricultural use; medicaments against artheriosclerosis; medicaments against restenosis; medicaments for tissue regeneration and tissue replacement; medicaments for cartilage regeneration; pharmaceutical and veterinary preparations for diabetes treatment; pharmaceutical and veterinary preparations for diabetes prophylaxis; medicaments against obesity; pharmaceutical and veterinary preparations for use in pets, livestock, wild animals, breeding animals and zoo animals against tumors; peptides for medical use; peptides for medical diagnostic use; peptidomimetics for medical use; peptiomimetics for medical diagnostic use; antibodies for medical use; antibodies for medical diagnostic use; DNA probes for medical use; DNA probes for medical diagnostic use; oligonucleotides for medical use; oligonucleotides for medical diagnostic use; small molecules for medical use
  • GS0091: Scientific control apparatus and instruments, namely microscopes, ELISA readers, scanners, fluorescence readers, and phosphorimagers; scientific measuring and checking apparatus and instruments, comprising filters and membranes used in the field of biotechnology and pharmaceuticals; computer programs for synthesis of chemicals used in industry and science; computer programs for immobilization of chemicals used in industry and science; computer programs for analysis of patterns on surfaces, namely for analysis of filters and membranes; computer programs for the screening of compounds
  • GS0401: Chemical processing or transformation of inorganic or organic compounds for third parties, namely synthesis of peptides, polypeptides and proteins, manufacture of immobilized enzyme substrates, proteinmimetica and peptidimimetica, synthesis of peptides with sterically hindered amino acids, synthesis of peptides with distinct secondary structures and/or multiple antigenic peptides, immobilization of products and compounds, compound libraries, enzyme substrates, proteinmimetica and peptidomimetica, modification of peptides and proteins, and transformation of biologically active peptides and peptidomimetica
  • GS0421: Laboratory services of a chemist, biologist, biochemist, biotechnologists, gene technologists, molecular biologists, pharmacists, medical doctor, protein chemist; scientific and industrial research; computer programming
Case File Event Statements
  • 5/20/2011 - 14 years ago
    37 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 2/3/2010 - 15 years ago
    36 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA
  • 2/3/2010 - 15 years ago
    35 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP
  • 10/24/2007 - 18 years ago
    34 - REVIEW OF CORRESPONDENCE COMPLETE Type: CORV
  • 10/18/2007 - 18 years ago
    33 - PAPER RECEIVED Type: MAIL
  • 12/11/2004 - 20 years ago
    32 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/8/2004 - 20 years ago
    31 - PAPER RECEIVED Type: MAIL
  • 11/9/2004 - 20 years ago
    30 - PAPER RECEIVED Type: MAIL
  • 10/19/2004 - 21 years ago
    29 - EXPARTE APPEAL TERMINATED Type: EXPT
  • 10/19/2004 - 21 years ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/27/2004 - 21 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/19/2004 - 21 years ago
    26 - PAPER RECEIVED Type: MAIL
  • 7/7/2004 - 21 years ago
    25 - NOTICE OF PUBLICATION Type: NPUB
  • 6/18/2004 - 21 years ago
    24 - PAPER RECEIVED Type: MAIL
  • 4/20/2004 - 21 years ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/20/2004 - 21 years ago
    22 - Sec. 1(B) CLAIM DELETED Type: 1.BD
  • 4/20/2004 - 21 years ago
    21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/5/2004 - 21 years ago
    20 - FAX SENT Type: FAXX
  • 2/25/2004 - 21 years ago
    19 - PAPER RECEIVED Type: MAIL
  • 2/17/2004 - 21 years ago
    18 - NON-FINAL ACTION MAILED Type: CNRT
  • 1/23/2004 - 21 years ago
    17 - CASE FILE IN TICRS Type: CFIT
  • 1/20/2004 - 21 years ago
    16 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 1/20/2004 - 21 years ago
    15 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 1/12/2004 - 21 years ago
    14 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 9/11/2003 - 22 years ago
    13 - PAPER RECEIVED Type: MAIL
  • 3/12/2003 - 22 years ago
    12 - FINAL REFUSAL MAILED Type: CNFR
  • 2/3/2003 - 22 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/3/2003 - 22 years ago
    10 - PAPER RECEIVED Type: MAIL
  • 1/15/2003 - 22 years ago
    9 - INQUIRY AS TO SUSPENSION MAILED Type: CNSI
  • 3/11/2002 - 23 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/18/2002 - 23 years ago
    7 - LETTER OF SUSPENSION MAILED Type: CNSL
  • 3/12/2002 - 23 years ago
    6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/1/2002 - 23 years ago
    5 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/11/2002 - 23 years ago
    4 - PAPER RECEIVED Type: MAIL
  • 3/1/2002 - 23 years ago
    3 - PAPER RECEIVED Type: MAIL
  • 8/27/2001 - 24 years ago
    2 - NON-FINAL ACTION MAILED Type: CNRT
  • 8/20/2001 - 24 years ago
    1 - ASSIGNED TO EXAMINER Type: DOCK